The tumor suppressor protein p53 acts as a transcriptional activator t
hat can mediate cellular responses to DNA damage by inducing apoptosis
and cell cycle arrest, p53 is a nuclear phosphoprotein, and phosphory
lation has been proposed to he a means by which the activity of p53 is
regulated, The cyclin-dependent kinase (CDK)-activating kinase (CAK)
was originally identified as a cellular kinase required for the activa
tion of a CDK-cyclin complex, and CAK is comprised of three subunits:
CDK7, cyclin H, and p36(MAT1). CAK is part of the transcription factor
IIH multiprotein complex, which is required for RNA polymerase II tra
nscription and nucleotide excision repair. Because of the similarities
between p53 and CAK in their involvement in the cell cycle, transcrip
tion, and repair, we investigated whether p53 could act as a substrate
for phosphorylation by CAK. While CDK7-cyclin H is sufficient for pho
sphorylation of CDK2, we show that p36(MAT1) is required for efficient
phosphorylation of p53 by CDK7-cyclin H, suggesting that p35(MAT1) ca
n act as a substrate specificity-determining factor for CDK7-cyclin H.
We have mapped a major site of phosphorylation by CAK to Ser-33 of p5
3 and have demonstrated as well that p53 is phosphorylated at this sit
e in vivo. Both wild-type and tumor-derived mutant p53 proteins are ef
ficiently phosphorylated by CAK. Furthermore, we show that p36 and p53
can interact both in vitro and in vivo. These studies reveal a potent
ial mechanism for coupling the regulation of p53 with DNA repair and t
he basal transcriptional machinery.